Previous 10 | Next 10 |
home / stock / bayzf / bayzf news
Evofem recently launched the first new non-hormonal birth control option in decades. Clinical efficacy falls short of the copper IUD, PARAGARD, but that device I believe may come with significant side effects. A trend in birth control centered on the woman's quality of life (safet...
TransCode Therapeutics has filed to raise $29 million in an IPO. The firm is developing treatments for metastatic cancer and other conditions. RNAZ has produced impressive results in preclinical mice studies. For further details see: TransCode Therapeutics Starts $29 Mil...
Citi analyst Yigal Nochomovitz has upgraded shares of Atara Biotherapeutics, Inc. (ATRA) to buy from hold and is maintaining his $27 price target.He notes that since early December, when the company announced a collaboration with Bayer (BAYZF) for two mesothelin CAR-T programs, ATA2271 and AT...
Bayer AG (BAYZF) Q4 2020 Earnings Conference Call February 25, 2021, 04:00 ET Company Participants Oliver Maier - Head, IR Werner Baumann - Chairman, CEO, Labor Director & Chief Sustainability Officer Wolfgang Nickl - CFO Heiko Schipper - Head, Consumer Health Division Liam Condon - Presi...
There is growing demand for AI use in drug development. Drug development deals go from $5 million to over $1 billion. Predictive Oncology has a unique platform using real patient samples in its AI process. Predictive Oncology could be undervalued if it can ink large or multipl...
Stocks finished the year strongly with cyclicals and energy stocks rallying strongly. I am continuing my monthly investment plans while awaiting a market correction or possibly a real crash once market euphoria has come down. My dividend income amounted to $379, up 30% sequentiall...
The time has come to look what we might want to look at as appealing investments going into February of 2021. We look at the areas of Financials, Real Estate, Industrials, IT and Pharma/Healthcare. Ongoing rising valuations make continued caution a necessity. Know your price targe...
In the last few days, the question of why more drug companies haven't been enlisted for vaccine production has come up. There are not "dozens of other pharma companies" who "stand ready" to produce these mRNA vaccines. Sanofi, one of the big vaccine players already (and one with t...
On January 13, ESSA announced a collaboration agreement with Janssen to evaluate ESSA's EPI-7386 in combo with Janssen's apalutamide and in combo with abiraterone acetate plus prednisone in patients with mCRPC. EPI-7386 is a novel approach to treat prostate cancer by targeting the N-t...
Bayer (BAYZF) becomes the latest European pharma giant to ramp up global vaccine production after agreeing to produce the COVID-19 vaccine from CureVac N.V. ([[CVAC]] +8.1%), which is currently undergoing a pivotal Phase 2b/3 trial globally.Expecting to launch the production in...
News, Short Squeeze, Breakout and More Instantly...
Bayer AG Registered Shares Company Name:
BAYZF Stock Symbol:
OTCMKTS Market:
NORTHAMPTON, MA / ACCESSWIRE / August 29, 2023 / Bayer - As climate change quickens, societal expectations increase and the threat of resistance grows, new crop protection solutions are imperative. Advances in the life sciences and data-driven technologies hold the key to expanding our pipeline ...
Monsanto Must Face Georgia State Jurors in Lawsuit Over Cancer-Causing Roundup Herbicide PR Newswire 11th Circuit opinion finds chemical giant subject to state's warning label laws Nachawati Law Group trial lawyers gearing up for next Roundup cancer trial in Au...
Bayer Runs Out of Appeals at US Supreme Court as Thousands of Cancer Lawsuits Await over Roundup Herbicide PR Newswire Fears Nachawati trial lawyers gearing up for next Roundup cancer trial in August WASHINGTON , June 22, 2022 /PRNewswire/ -- Baye...